John McKew
President bei LUMOS PHARMA, INC.
Vermögen: 48 371 $ am 31.03.2024
Profil
John C.
McKew's current job(s) include being an Associate Professor at Boston University School of Medicine and serving as the President & Chief Scientific Officer at Lumos Pharma, Inc. Formerly, Dr. McKew held positions such as Chairman at the American Chemical Society, Director at Wyeth Research, Scientific Director at the National Center for Advancing Translational Sciences from 2013 to 2014, Chief Scientific Officer at NewLink Genetics Corp.
in 2020, Vice President-Research at aTyr Pharma, Inc. from 2014 to 2016, and Principal at the National Institutes of Health from 2010 to 2014.
Additionally, he served as the Chief Scientific Officer at Lumos Pharma Sub, Inc. from 2016 to 2020.
Dr. McKew completed his undergraduate studies at Stony Brook University and obtained a doctorate degree from the University of California, Davis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LUMOS PHARMA, INC.
0,21% | 03.04.2024 | 17 153 ( 0,21% ) | 48 371 $ | 31.03.2024 |
Aktive Positionen von John McKew
| Unternehmen | Position | Beginn |
|---|---|---|
| LUMOS PHARMA, INC. | President | 01.08.2021 |
| Boston University School of Medicine | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John McKew
| Unternehmen | Position | Ende |
|---|---|---|
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Chief Tech/Sci/R&D Officer | 31.03.2020 |
| ATYR PHARMA, INC. | Chief Tech/Sci/R&D Officer | 01.01.2016 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01.01.2014 |
National Center for Advancing Translational Sciences
 National Center for Advancing Translational Sciences National AgencyGovernment National Center for Advancing Translational Sciences studies translation on a system-wide level as a scientific and operational problem. The company was founded in 2012 and is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | 01.01.2014 |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Director/Board Member | - |
Ausbildung von John McKew
| Stony Brook University | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| LUMOS PHARMA, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Commercial Services |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National Center for Advancing Translational Sciences studies translation on a system-wide level as a scientific and operational problem. The company was founded in 2012 and is headquartered in Rockville, MD. | Government |
